Literature DB >> 17626975

In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment.

Olavio R Baricordi, Marcello Govoni, Roberta Rizzo, Francesco Trotta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626975      PMCID: PMC1954723          DOI: 10.1136/ard.2006.064022

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads.

Authors:  Sine Hylenius; Anne-Marie Nybo Andersen; Mads Melbye; Thomas Vauvert F Hviid
Journal:  Mol Hum Reprod       Date:  2004-01-29       Impact factor: 4.025

Review 2.  Methotrexate pharmacogenomics.

Authors:  J M Kremer
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

3.  Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis.

Authors:  L B Hughes; T M Beasley; H Patel; H K Tiwari; S L Morgan; J E Baggott; K G Saag; J McNicholl; L W Moreland; G S Alarcón; S L Bridges
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

4.  The HLA-G genotype is associated with IL-10 levels in activated PBMCs.

Authors:  Roberta Rizzo; Thomas Vauvert F Hviid; Marina Stignani; Alessandra Balboni; Maria Teresa Grappa; Loredana Melchiorri; Olavio R Baricordi
Journal:  Immunogenetics       Date:  2005-04-02       Impact factor: 2.846

5.  Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.

Authors:  E Fainardi; R Rizzo; L Melchiorri; M Castellazzi; E Paolino; M R Tola; E Granieri; O R Baricordi
Journal:  Mult Scler       Date:  2006-02       Impact factor: 6.312

6.  HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis.

Authors:  Roberta Rizzo; Michele Rubini; Marcello Govoni; Melissa Padovan; Loredana Melchiorri; Marina Stignani; Sabrina Carturan; Stefano Ferretti; Francesco Trotta; Olavio R Baricordi
Journal:  Pharmacogenet Genomics       Date:  2006-09       Impact factor: 2.089

7.  Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma.

Authors:  Roberta Rizzo; Cristina E Mapp; Loredana Melchiorri; Piero Maestrelli; Annalisa Visentin; Stefano Ferretti; Ilaria Bononi; Deborah Miotto; Olavio R Baricordi
Journal:  J Allergy Clin Immunol       Date:  2005-03       Impact factor: 10.793

Review 8.  HLA-G and MIC expression in tumors and their role in anti-tumor immunity.

Authors:  Barbara Seliger; Hinrich Abken; Soldano Ferrone
Journal:  Trends Immunol       Date:  2003-02       Impact factor: 16.687

9.  A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.

Authors:  T Fujii; A Ishitani; D E Geraghty
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

10.  Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts.

Authors:  L Crisa; M T McMaster; J K Ishii; S J Fisher; D R Salomon
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

  10 in total
  3 in total

1.  PharmGKB summary: methotrexate pathway.

Authors:  Torben S Mikkelsen; Caroline F Thorn; Jun J Yang; Cornelia M Ulrich; Deborah French; Gianluigi Zaza; Henry M Dunnenberger; Sharon Marsh; Howard L McLeod; Kathy Giacomini; Mara L Becker; Roger Gaedigk; James Steven Leeder; Leo Kager; Mary V Relling; William Evans; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-10       Impact factor: 2.089

2.  "HLA-G 3'UTR gene polymorphisms and rheumatic heart disease: a familial study among South Indian population".

Authors:  Maheshkumar Poomarimuthu; Sivakumar Elango; Sambath Soundrapandian; Jayalakshmi Mariakuttikan
Journal:  Pediatr Rheumatol Online J       Date:  2017-02-01       Impact factor: 3.054

3.  HLA-G expression on blasts and tolerogenic cells in patients affected by acute myeloid leukemia.

Authors:  Grazia Locafaro; Giada Amodio; Daniela Tomasoni; Cristina Tresoldi; Fabio Ciceri; Silvia Gregori
Journal:  J Immunol Res       Date:  2014-03-13       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.